The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain
Abstract
The BRPF (Bromodomain and PHD Finger-containing) protein family are important scaffolding proteins for assembly of MYST histone acetyltransferase complexes. A selective benzimidazolone BRPF1 inhibitor showing micromolar activity in a cellular target engagement assay was recently described. Herein, we report the optimization of this series leading to the identification of a superior BRPF1 inhibitor suitable for in vivo studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the chemical probes (+)-JQ1 (BRD4), A395 (EED), T-26c (MMP-13), and GSK-6853 (BRPF1) are all ALARM NMR-negative (Figure 5) (Bamborough et al., 2016; Filippakopoulos et al., 2010; He et al., 2017; Nara et al., 2014).”
From ALARM NMR for HTS Triage and Chemical Probe Validation (2018) · cites this paper as Bamborough et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Suppression of inflammation by a synthetic histone mimic
Nicodeme, E., Jeffrey, K. L., Schaefer, U., Beinke, S., Dewell, S., Chung, C.-W., Chandwani, R., Marazzi, I., Wilson, P., Coste, H., et al. (2010) · Nature · doi:10.1038/nature09589 · Cited by 1,563
Self-citationPalmer, W. S., Poncet-Montange, G., Liu, G., Petrocchi, A., Reyna, N., Subramanian, G., Theroff, J., Yau, A., Kost-Alimova, M., Bardenhagen, J. P., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00405 · Cited by 168
Research works printed but not linked: 20
- Filippakopoulos, 2012, Histone recognition and large-scale structural analysis of the human bromodomain family, Cell, 149, 214, 10.1016/j.cell.2012.02.013 · DOI · Paper page
- Chung, 2011, Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains, J. Med. Chem., 54, 3827, 10.1021/jm200108t · DOI · Paper page
- Garnier, 2014, BET bromodomain inhibitors: a patent review, Expert Opin. Ther. Pat., 24, 185, 10.1517/13543776.2014.859244 · DOI
- Mirguet, 2013, Discovery of epigenetic regulator I-BET762: Lead optimization to afford a clinical candidate inhibitor of the BET bromodomains, J. Med. Chem., 56, 7501, 10.1021/jm401088k · DOI · Paper page
- Filippakopoulos, 2014, Targeting bromodomains: epigenetic readers of lysine acetylation, Nat. Rev. Drug Discovery, 13, 337, 10.1038/nrd4286 · DOI · Paper page
- Muller, 2014, Discovery of BET bromodomain inhibitors and their role in target validation, MedChemComm, 5, 288, 10.1039/c3md00291h · DOI
- Chung, 2012, Bromodomains: a new target class for small molecule drug discovery, Drug Discovery Today: Ther. Strategies, 9, e111, 10.1016/j.ddstr.2011.12.002 · DOI
- Carlson, 2014, The MOZ Histone Acetyltransferase in Epigenetic Signaling and Disease, J. Cell. Physiol., 229, 1571, 10.1002/jcp.24617 · DOI
- Ullah, 2008, Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes, Mol. Cell. Biol., 28, 6828, 10.1128/MCB.01297-08 · DOI · Paper page
- Poplawski, 2014, Molecular insights into recognition of N-terminal histone modifications by the BRPF1 bromodomain, J. Mol. Biol., 426, 1661, 10.1016/j.jmb.2013.12.007 · DOI
- Qin, 2011, Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF), J. Biol. Chem., 286, 36944, 10.1074/jbc.M111.244400 · DOI
- Laue, 2008, The multidomainprotein BRPF1 binds histones and is required for Hox gene expressionand segmental identity, Development, 135, 1935, 10.1242/dev.017160 · DOI
- Vezzoli, 2010, Molecular basis of histone H3K36me3 recognition by the PWWP domain of Brpf1, Nat. Struct. Mol. Biol., 17, 617, 10.1038/nsmb.1797 · DOI · Paper page
- Young, 2011, getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity, Drug Discovery Today, 16, 822, 10.1016/j.drudis.2011.06.001 · DOI · Paper page
- Demont, 2014, 1,3-Dimethyl Benzimidazolones are potent, selective inhibitors of the BRPF1 bromodomain, ACS Med. Chem. Lett., 5, 1190, 10.1021/ml5002932 · DOI
- Bennett, 2016, Discovery of a chemical tool inhibitor targeting the bromodomains of TRIM24 and BRPF1, J. Med. Chem., 59, 1642, 10.1021/acs.jmedchem.5b00458 · DOI
- Kuntz, 1999, The maximal affinity of ligands, Proc. Natl. Acad. Sci. U. S. A., 96, 9997, 10.1073/pnas.96.18.9997 · DOI · Paper page
- Hopkins, 2004, Ligand efficiency: a useful metric for lead selection, Drug Discovery Today, 9, 430, 10.1016/S1359-6446(04)03069-7 · DOI · Paper page
- Goodford, 1985, A computational procedure for determining energetically favorable binding sites on biologically important macromolecules, J. Med. Chem., 28, 849, 10.1021/jm00145a002 · DOI · Paper page
- Deplus, 2013, TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS, EMBO J., 32, 645, 10.1038/emboj.2012.357 · DOI · Paper page
Cited by
Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Mohammad, H. P., Barbash, O., & Creasy, C. L. (2019) · Nature Medicine · doi:10.1038/s41591-019-0376-8 · Cited by 413
Bromodomains: a new target class for drug development
Cochran, A. G., Conery, A. R., & Sims, R. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0030-7 · Cited by 412
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Hemming, M. L., Benson, M. R., Loycano, M. A., Anderson, J. A., Andersen, J. L., Taddei, M. L., Krivtsov, A. V., Aubrey, B. J., Cutler, J. A., Hatton, C., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0646 · Cited by 39
ALARM NMR for HTS Triage and Chemical Probe Validation
Dahlin, J. L., Cuellar, M., Singh, G., Nelson, K. M., Strasser, J. M., Rappe, T., Xia, Y., Veglia, G., & Walters, M. A. (2018) · Current Protocols in Chemical Biology · doi:10.1002/cpch.35 · Cited by 25
Metadata
- Authors
- Bamborough, P., Barnett, H. A., Becher, I., Bird, M. J., Chung, C.-W., Craggs, P. D., Demont, E. H., Diallo, H., Fallon, D. J., Gordon, L. J., Grandi, P., Hobbs, C. I., Hooper-Greenhill, E., Jones, E. J., Law, R. P., Le Gall, A., Lugo, D., Michon, A.-M., Mitchell, D. J., Prinjha, R. K., Sheppard, R. J., Watson, A. J. B., & Watson, R. J.
- Affiliations
- GlaxoSmithKline , , , Gunnels Wood Road , Stevenage, ,
- GlaxoSmithKline , , Meyerhofstrasse 1 , ,
- University of Strathclyde , , Thomas Graham Building, 295 Cathedral Street , ,
- Venue
- ACS Medicinal Chemistry Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-05-09
- Volume
- 7
- Issue
- 6
- Pages
- 552-557
- ISSN
- 1948-5875
- Cited by
- 67
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain. https://app.cochat.ai/papers/10.1021/acsmedchemlett.6b00092
- The paper
- Bamborough, P., Barnett, H. A., Becher, I., Bird, M. J., Chung, C.-W., Craggs, P. D., Demont, E. H., Diallo, H., Fallon, D. J., Gordon, L. J., Grandi, P., Hobbs, C. I., Hooper-Greenhill, E., Jones, E. J., Law, R. P., Le Gall, A., Lugo, D., Michon, A.-M., Mitchell, D. J., . . . Watson, R. J. (2016). GSK6853, a Chemical Probe for Inhibition of the BRPF1 Bromodomain. ACS Medicinal Chemistry Letters. https://doi.org/10.1021/acsmedchemlett.6b00092
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.